TFF Pharmaceuticals, Inc.

NASDAQ:TFFP

1.63 (USD) • At close November 7, 2024
Bedrijfsnaam TFF Pharmaceuticals, Inc.
Symbool TFFP
Munteenheid USD
Prijs 1.63
Beurswaarde 5,649,645
Dividendpercentage 0%
52-weken bereik 1.35 - 11
Industrie Biotechnology
Sector Healthcare
CEO Dr. Harlan F. Weisman
Website https://www.tffpharma.com

An error occurred while fetching data.

Over TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and

Vergelijkbare Aandelen

Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc.

SRTS

6.54 USD

Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc.

ABOS

3.17 USD

scPharmaceuticals Inc. logo

scPharmaceuticals Inc.

SCPH

4.32 USD

Allakos Inc. logo

Allakos Inc.

ALLK

1.35 USD

Spok Holdings, Inc. logo

Spok Holdings, Inc.

SPOK

16.76 USD

Meihua International Medical Technologies Co., Ltd. logo

Meihua International Medical Technologies Co., Ltd.

MHUA

0.612 USD

PDS Biotechnology Corporation logo

PDS Biotechnology Corporation

PDSB

3.28 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)